This test is most useful if any of these apply to you.
If you or your child has reacted to eggs, or if eczema, hives, or stomach symptoms keep appearing after meals containing egg, the question is usually the same: is this a true egg allergy, and how serious is it? A blood test for IgE (immunoglobulin E, an antibody your immune system makes during allergic reactions) against Gal d 3, one of the specific proteins inside egg white, helps add detail to that picture.
Gal d 3 is one piece of a larger puzzle. It works best alongside a whole egg white IgE test and, in most cases, ovomucoid (Gal d 1). On its own it is a secondary marker, but as part of a pattern of sensitization to several egg proteins, it can point toward an allergy that is less likely to be outgrown.
The test detects IgE antibodies in your blood that recognize Gal d 3 (also called conalbumin or ovotransferrin), an iron-binding protein that makes up roughly 12 percent of egg white. It does not measure the protein itself. It measures whether your immune system has built antibodies against it, which is what defines sensitization.
IgE antibodies are made by a type of immune cell called a plasma cell, which develops from B cells (the antibody-producing cells of your immune system). When these antibodies recognize Gal d 3, they can bind to mast cells in your tissues and trigger the release of histamine and other chemicals that cause allergy symptoms. A positive Gal d 3 IgE means that machinery is in place. It does not, by itself, prove that you will react to eating egg.
Egg white contains several proteins that can trigger allergy, and they are not equally important. Gal d 1 (ovomucoid) is heat-stable, which means it survives cooking and is the protein most linked to reactions after eating baked or heated egg. Gal d 3 is heat-labile, meaning it breaks down with cooking. That difference matters because most clinically meaningful egg allergy in older children and adults involves reactions to cooked egg, which is more closely tied to Gal d 1.
In a Finnish study of children with suspected egg allergy, Gal d 3 had moderate accuracy for predicting reactions to heated egg, while Gal d 1 performed clearly better. In a large infant cohort, adding Gal d 1, 2, 3, or 5 did not improve the diagnosis of current egg allergy over whole egg white IgE alone. In Korean children, none of the individual egg white components, including Gal d 3, reliably separated children who reacted on food challenge from those who did not.
Where Gal d 3 earns its place is in prognosis. The HealthNuts cohort found that children sensitized to multiple egg components, including Gal d 1, 2, 3, or 5, had higher odds of persistent raw egg allergy compared with those sensitized to fewer components. Sensitization to Gal d 1 alone also increased the odds, though to a smaller degree.
On its own, a positive Gal d 3 did not strongly predict persistence. The signal came from the breadth of the sensitization pattern. Children whose immune systems recognize many egg proteins, Gal d 3 included, tend to have a more entrenched allergy that is slower to fade.
Egg allergy is not one disease. Some people react only to raw or undercooked egg, while others react to thoroughly baked egg in muffins or cakes. Component testing helps separate these phenotypes.
This is why Gal d 3 is best read as a piece of a profile, not a standalone verdict. A positive Gal d 3 alongside a positive Gal d 1 and elevated whole egg white IgE paints a different picture than an isolated low-level positive Gal d 3 in a child who eats baked egg regularly without symptoms.
The strongest evidence around Gal d 3 ties it to whether an egg allergy will last. In the HealthNuts study, sensitization across the full panel of egg components (Gal d 1, 2, 3, and 5) was a marker of more durable allergy. Children with this multi-component profile were less likely to grow out of their reaction to raw egg.
Falling egg white IgE levels over time go in the other direction. In a Korean study of children with egg allergy, the rate at which egg white IgE dropped over 12 months independently predicted whether a child would acquire tolerance, often making oral food challenges easier to plan.
Infants with atopic dermatitis (eczema in babies and young children) often turn up positive on egg IgE testing. Early egg sensitization frequently travels with other allergic conditions, including house dust mite sensitization, asthma, and rhinitis. A positive Gal d 3, especially within a broader sensitization profile, can mark a higher-risk atopic trajectory worth watching.
It is common for someone to test positive on Gal d 3 IgE but eat baked goods containing egg without any problem. This is not a paradox. The test detects sensitization, the presence of IgE antibodies, not clinical allergy. Sensitization means the immune system has built the machinery for a reaction. Clinical allergy means that machinery actually fires when you eat egg.
Many people are sensitized without ever reacting. This is why egg IgE results, including Gal d 3, must always be read against your actual eating history and symptoms. The gold standard for confirming clinical egg allergy remains a supervised oral food challenge, where small, escalating doses of egg are eaten under medical supervision.
A single Gal d 3 IgE value is a snapshot. The trajectory matters more. In children with diagnosed egg allergy, egg white IgE levels that fall over months tend to precede tolerance. Levels that hold steady or climb suggest a more persistent course.
If you are using this test to monitor egg allergy in a child, plan for a baseline measurement, then a follow-up at 6 to 12 months. If the levels are dropping and there are no recent reactions, a supervised oral food challenge may be reasonable. If they are stable or rising, continued avoidance and re-testing in another 6 to 12 months is usually the path forward. For adults with an established egg allergy or borderline sensitization, annual re-testing is a reasonable cadence unless symptoms change.
A positive IgE does not equal an allergy. The most common pitfall with Gal d 3 (and any egg component) is treating a positive number as a diagnosis. Many people have measurable IgE to egg proteins but tolerate egg fine. The opposite can also happen: a low Gal d 3 with a clear reaction history still means you should avoid the food.
If your Gal d 3 result does not fit your eating history, the next step is not to change your diet based on the number alone. The decision pathway typically looks like this: pair the Gal d 3 with a whole egg white IgE and Gal d 1 result if you do not already have them, then bring the full panel to an allergist. If you have never had a reaction and are eating egg comfortably, the most useful next step is often no change at all.
If you have had reactions, a positive Gal d 3 supports continued caution and helps the allergist decide whether a supervised oral food challenge is appropriate, and at what stage (baked egg first, then lightly cooked, then raw). If you are considering oral immunotherapy for an established egg allergy, the full component panel, including Gal d 3, helps profile the allergy's likely severity and persistence.
For a complete egg allergy workup, Gal d 3 is one input among several. Whole egg white IgE provides the broadest sensitivity, especially in young children. Gal d 1 is the strongest single marker for heated egg reactivity and allergy persistence. A skin prick test can add information at the allergist's office. Where available, the basophil activation test (a lab assay measuring how strongly your immune cells respond to the allergen in a test tube) refines borderline cases. An oral food challenge remains the only definitive test for true clinical allergy.
Evidence-backed interventions that affect your Egg White (Gal d 3) IgE level
Egg White (Gal d 3) IgE is best interpreted alongside these tests.